Stephens Neil, King Emma, Lyall Catherine
Social Sciences and Communications, Brunel University London, Kingston Lane, Uxbridge, Middlesex 01895268460, UK.
University of Stirling, Stirling, UK.
Biosocieties. 2018 Jun;13:368-388. doi: 10.1057/s41292-017-0072-1. Epub 2018 Jan 15.
Tissue engineering is a set of biomedical technologies, including stem cell science, which seek to grow biological tissue for a diversity of applications. In this paper, we explore two emergent tissue engineering technologies that seek to cause a step change in the upscaling capacity of cell growth: cultured blood and cultured meat. Cultured blood technology seeks to replace blood transfusion with a safe and affordable bioengineered replacement. Cultured meat technology seeks to replace livestock-based food production with meat produced in a bioreactor. Importantly, cultured meat technology straddles the industrial contexts of biomedicine and agrifood. In this paper, we articulate (i) the shared and divergent promissory trajectories of the two technologies and (ii) the anticipated market, consumer, and regulatory contexts of each. Our analysis concludes by discussing how the sectoral ontologies of biomedicine and agri-food impact the performative capacity of each technology's promissory trajectory.
组织工程是一系列生物医学技术，包括干细胞科学，旨在培育用于多种应用的生物组织。在本文中，我们探讨了两种新兴的组织工程技术，它们试图在扩大细胞生长能力方面带来跨越式变化：培养血液和培养肉。培养血液技术旨在用安全且经济实惠的生物工程替代品取代输血。培养肉技术旨在用生物反应器中生产的肉类取代基于牲畜的食品生产。重要的是，培养肉技术跨越了生物医学和农业食品的产业背景。在本文中，我们阐述了（i）这两种技术共同和不同的预期发展轨迹，以及（ii）每种技术预期的市场、消费者和监管背景。我们的分析最后讨论了生物医学和农业食品的部门本体如何影响每种技术预期发展轨迹的实践能力。
